Ricerca
La bronchiolite: aderenza alle linee guida
Bronchiolitis: compliance with guidelines
Martina Rezzuto1, Carla Russo1, Claudia Mandato2, Daniele De Brasi2, Fabio Savoia3, Paolo Siani1,2
1Dipartimento Materno-Infantile, AOU Federico II, Napoli
2UOC Pediatria 1; 3Registro Tumori Infantili della Regione Campania, AORN “Santobono-Pausilipon”, Napoli
Dicembre 2018 - pagg. 641 -646
Abstract
Background - Bronchiolitis is the most common infection of the lower respiratory tract during the first year of life. The American Academy of Pediatrics (AAP) guidelines and the Italian Society of Paediatrics (SIP) Consensus underline that the diagnosis of bronchiolitis is based on the clinical history and the objective examination and that the key points of the treatment are mainly to guarantee a proper nutrition/hydration and to administer oxygen where necessary.
Objectives - To assess the compliance with international and national guidelines in hospital settings before and after sharing and discussing a care protocol.
Materials and Methods - Two groups consisting of 27 patients each affected by bronchiolitis were studied. The children of the first were hospitalised in 2014-2015 and were managed without complying with the unit protocol and those of the second group were hospitalised in 2015-2016, after the protocol sharing. Treatment modalities and the incidence of complication were compared.
Results - Following the sharing of the clinical protocol a trend towards the decrease in the use of the antibiotic therapy and steroids was observed. A larger use of nebuliser therapy with hypertonic solution was observed with respect to the sole physiological solution or the steroidal one. The duration of hospitalisation was similar in the two considered periods. No major complications were observed in both the above two periods.
Conclusions - The present study, though it considers a low number of samples, shows that the sharing of an internal protocol for the management of paediatric patients can allow resources to be optimised as well as ineffective and potentially dangerous treatments to be avoided.
Objectives - To assess the compliance with international and national guidelines in hospital settings before and after sharing and discussing a care protocol.
Materials and Methods - Two groups consisting of 27 patients each affected by bronchiolitis were studied. The children of the first were hospitalised in 2014-2015 and were managed without complying with the unit protocol and those of the second group were hospitalised in 2015-2016, after the protocol sharing. Treatment modalities and the incidence of complication were compared.
Results - Following the sharing of the clinical protocol a trend towards the decrease in the use of the antibiotic therapy and steroids was observed. A larger use of nebuliser therapy with hypertonic solution was observed with respect to the sole physiological solution or the steroidal one. The duration of hospitalisation was similar in the two considered periods. No major complications were observed in both the above two periods.
Conclusions - The present study, though it considers a low number of samples, shows that the sharing of an internal protocol for the management of paediatric patients can allow resources to be optimised as well as ineffective and potentially dangerous treatments to be avoided.
Parole chiave
Classificazione MeSH
Contenuto riservato
Per leggere l'articolo completo è necessario effettuare il login.
Non sei ancora registrato? Registrati
Bibliografia
1. Ricci V, Delgado Nunes V, Murphy MS, et al. Bronchiolitis in children: summary of NICE guidance. BMJ 2015;350:h2305.
2. Ralston SL, Lieberthal AS, Meissner HC, et al; American Academy of Pediatrics. Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis. Pediatrics 2014;134(5):e1474-502.
3. Sanchez-Luna M, Elola FJ, Fernandez-Perez C, Bernal JL, Lopez-Pineda A. Trends in respiratory syncytial virus bronchiolitis hospitalizations in children less than 1 year: 2004-2012. Curr Med Res Opin 2016;32(4): 693-8.
4. Schibler A, Pham TM, Dunster KR, et al. Reduced intubation rates for infants after introduction of high-flow nasal prong oxygen delivery. Intensive Care Med 2011;37(5):847-52.
5. Oakley E, Chong V, Borland M, et al. Intensive care unit admissions and ventilation support in infants with bronchiolitis. Emerg Med Australas 2017;29(4):421-8.
6. Cozzi G, Pusceddu S, Mambelli L, Barbi E, Marchetti M. Le nuove linee guida sulla bronchiolite. Medico e Bambino 2015;34(6): 369-75.
7. National Collaborating Centre for Women’s and Children’s Health (UK). Bronchiolitis: diagnosis and management of bronchiolitis in children. Clinical Guideline NG9, 2015.
8. Morawetz D, Cheah E, Barton R, Standish J, Connell TG. Is nebulised hypertonic saline useful as an adjunctive treatment for acute bronchiolitis in infants and children less than 24 months of age? J Paediatr Child Health 2011;47(12):922-6.
9. Zhang L, Mendoza-Sassi RA, Wainwright C, et al. Nebulised hypertonic saline solution for acute bronchiolitis in infants. Cochrane Database Syst Rev 2013;(7):CD006458.
10. Flores P, Mendes AL, Neto AS. A randomized trial of nebulized 3% hypertonic saline with salbutamol in the treatment of acute bronchiolitis in hospitalized infants. Pediatr Pulmonol 2016;51(4):418-25.
11. Everard ML, Hind D, Ugonna K, et al; SABRE Study Team. SABRE: a multicentre randomised control trial of nebulised hypertonic saline in infants hospitalised with acute bronchiolitis. Thorax 2014;69(12):1105-12.
12. Gadomski AM, Brower M. Bronchodilators for bronchiolitis. Cochrane Database Syst Rev 2010;(12):CD001266.
13. De Benedictis FM, Bush A. Corticosteroids in respiratory diseases in children. Am J Respir Crit Care Med 2012;185(1):12-23.
14. De Brasi D, Pannuti F, Antonelli F, de Seta F, Siani P, de Seta L. Therapeutic approach to bronchiolitis: why pediatricians continue to overprescribe drugs? Ital J Pediatr 2010;36:67.
15. Johnson LW, Robles J, Hudgins A, Osburn S, Martin D, Thompson A. Management of bronchiolitis in the Emergency Department: impact of evidence-based guidelines? Pediatrics 2013;131(Suppl 1):S103-9.
16. Ho SW, Huang KY, Teng YH, Ku MS, Chiou JY. Practice variations between emergency physicians and pediatricians in treating acute bronchiolitis in the Emergency Department: a nationwide study. J Emerg Med 2015;48(5):536-41.
17. Brand PL, Vaessen-Verberne AA; Dutch Paediatric Respiratory Society. Differences in management of bronchiolitis between hospitals in The Netherlands. Eur J Pediatr 2000; 159(5):343-7.
18. Barben J, Kuehni CE, Trachsel D; Hammer J; Swiss Paediatric Respiratory Research Group. Management of acute bronchiolitis: can evidence based guidelines alter clinical practice? Thorax 2008;63(12):1103-9.
19. Baron J, El-Chaar G. Hypertonic saline for the treatment of bronchiolitis in infants and young children: a critical review of the literature. J Pediatr Pharmacol Ther 2016;21 (1):7-26.
20. Pusceddu S, Cozzi G. Soluzione salina ipertonica in corso di bronchiolite acuta: fare meno è fare di più? Medico e Bambino 2015; 34(9):581-584
21. Silver AH, Esteban-Cruciani N, Azzarone G, et al. 3% hypertonic saline versus normal saline in impatient bronchiolitis: a randomized controlled trial. Pediatrics 2015;136(6): 1036-43.
22. Angoulvant F, Bellêttre X, Milcent K, et al; Efficacy of 3% Hypertonic Saline in Acute Viral Bronchiolitis (GUERANDE) Study Group. Effect of nebulized hypertonic saline treatment in Emergency Departments on the hospitalization rate for acute bronchiolitis: a randomized clinical trial. JAMA Pediatr 2017;171(8):e171333.
23. Morikawa Y, Miura M, Furuhata MY, et al; Tokyo Pediatric Clinical Research Network. Nebulized hypertonic saline in infants hospitalized with moderately severe bronchiolitis due to RSV infection: a multicenter randomized controlled trial. Pediatr Pulmonol 2018;53(3):358-65.
Corrispondenza: martinarezzuto@gmail.com